UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000012210 |
|---|---|
| Receipt number | R000014276 |
| Scientific Title | Observational study for treatment outcome in patients with HER2-positive metastatic breast cancer who received pertuzumab combination chemotherapy. |
| Date of disclosure of the study information | 2013/11/05 |
| Last modified on | 2020/05/10 12:19:12 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/11/04 20:43:13 | ||
| 2 | Update | 2017/05/08 19:30:36 | Name of primary person or sponsor Organization |
|
| 3 | Update | 2019/11/09 14:02:45 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 4 | Update | 2019/11/09 14:12:08 | Date of IRB Last follow-up date |
|
| 5 | Update | 2020/05/10 12:16:31 | Recruitment status |
|
| 6 | Update | 2020/05/10 12:19:12 | Number of participants that the trial has enrolled |
